Back to Fundings Eye Point Pharmaceuticals, Inc. announced it raised $9.47 Million in an initial filing from an offering of $35 Million PUBLIC · EYPT Apr 12, 2018Amount Raised
$9.47 Million
WatertownBiotechnology Healthcare Health Care Therapeutics Pharmaceutical Company
EyePoint Pharmaceuticals, Inc.
Location
480 PLEASANT STREET
Watertown, Massachusetts, United States
About
EyePoint Pharmaceuticals, Inc. is committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases.
Fundz sees it the moment EyePoint Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Verified contacts 10 people are listed at EyePoint Pharmaceuticals…. We don't have their email yet. See plans and pricing EyePoint Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.
Track this with Fundz
Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API , with transparent published pricing.
Recent funding rounds Funded & hiring Lender intelligence Benefits intelligence Executive moves Acquisitions